Skip to main content
. 2013 Oct 9;13:45. doi: 10.1186/1472-6823-13-45

Table 3.

Summary of case reports with pituitary and adrenal involvement in patients with lymphoma

Age/gender Pathology Presenting symptoms Involved sites Lymphoma treatment Hormonal treatment Prognosis, survival Reference
77/M
NHL diffuse large cell
Hyponatremia, Hypoglycemia, Weakness, Confusion
Pituitary gland, Bilateral adrenal glands
No treatment
T4, GC
Died, 9 weeks
[5]
59/M
DLBCL
Weakness, Ptosis, Mild Hyponatremia, Headache
Pituitary gland, Bilateral adrenal glands
R-CHOP, IT MTX
T4, GC, T, Fludro
Alive, 18 months
[6]
77/M
DLBCL
Fever, Hyponatremia, Ptosis
Pituitary gland, Bilateral adrenal glands, Liver, Spleen, Bone marrow
CHOP, IT MTX
GC
Died, 12 months in remission
[1]
63/M DLBCL Polyuria, Polydipsia, Miosis, Ptosis, Hypohidrosis of his left side Pituitary gland, Bilateral adrenal glands, Lung R-CHOP, HD-MTX, IT MTX, auto-HSCT T4, GC, Desmo Alive, 15 months This report

M male, NHL non-Hodgkin’s lymphoma, DLBCL diffuse large B-cell lymphoma, CHOP cyclophosphamide, doxorubicin, vincristine, prednisolone, IT intrathecal injection, MTX methotrexate, R-CHOP rituximab combined with CHOP.

HD high dose, auto-HSCT autologous hematopoietic stem cell transplantation, T4 thyroxin, GC glucocorticoid, T testosterone, Desmo desmopressin, Fludro fludrocortisone.